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Introduction {#sec1}
============

Autophagy is an intracellular recycling process that maintains cell homeostasis during stress. Autophagy occurs constitutively as a housekeeping process but is acutely upregulated upon insults, such as nutrient starvation. During autophagy, new vesicular organelles form, called autophagosomes. Autophagosome formation involves growth of a cup-shaped phagophore membrane that expands and encapsulates cargo, such as proteins and whole organelles \[[@bib1]\]. These cargoes are trapped inside the closed, fully formed autophagosome. The autophagosome terminally fuses with the lysosome, resulting in destruction of the autophagosomal contents and recycling of macromolecules. Autophagy is an essential process for animal life and conserved from yeast to humans. The importance of autophagy for physiology is underlined by its involvement in pathologies, such as cancer, neurodegeneration, and infection.

Autophagosome formation is controlled by conserved signaling and machinery proteins called Atg proteins in yeast and mammals. These proteins localize to, and are markers of, the forming autophagosome. In mammals, formation is initiated by the ULK protein kinase complex, which phosphorylates and activates the ATG14-Beclin1-phosphatidylinositol 3-phosphate (PI3P) kinase complex. This results in a pool of PI3P at autophagosome formation sites on the endoplasmic reticulum, called omegasomes \[[@bib2]\], and recruitment of DFCP1 and WIPI proteins, PI3P-binding effectors. WIPI2b recruits the ATG12--5-16L1 complex to the phagophore membrane, which mediates the lipidation of cytosolic ATG8 proteins by the lipid phosphatidylethanolamine and membrane association \[[@bib3]\]. Vesicles containing the transmembrane protein ATG9 are also thought to contribute to autophagosome formation \[[@bib4], [@bib5]\]. In yeast, there is one ATG8 protein, but in mammals, there are multiple ATG8 orthologs. In humans, the ATG8 proteins comprise two subfamilies: LC3s and GABARAPs \[[@bib6]\]. These ATG8 proteins function in formation and closure of the phagophore membrane and fusion of autophagosomes with lysosomes \[[@bib7], [@bib8], [@bib9]\]. ATG8 proteins also bind autophagy receptor proteins, such as p62, which specifically target cargoes into the autophagosome for degradation, and autophagy adaptors, which confer additional functionality but are not degraded by autophagy \[[@bib10]\]. The functional differences between the LC3 and GABARAP subfamilies, and how these proteins are specifically regulated, are poorly understood. ATG8s have many interactors, often mediated through LC3-interacting region (LIR) motifs \[[@bib11]\] present in cargo adaptors and receptors \[[@bib10], [@bib12]\]. How LIR-containing proteins specifically regulate ATG8s is a subject of intense investigation.

We have shown that GABARAP localizes at the pericentriolar material of the centrosome \[[@bib13]\]. Centrosomes contain a pair of centrioles embedded in a matrix of coiled-coil proteins called the pericentriolar material (PCM) \[[@bib14]\], which also contains microtubule-nucleating factors that enable the centrosome to function as a microtubule-organizing center. Electron-dense granules called centriolar satellites (CSs) surround the centrosome and are transported along microtubules \[[@bib15]\]. PCM1 is the archetypal CS marker protein providing the structural scaffold for CSs \[[@bib15], [@bib16]\]. PCM1 is a large (∼230 kDa) coiled-coil-containing protein that self-oligomerizes and binds other CS proteins, such as the E3 ligase Mib1 \[[@bib17], [@bib18], [@bib19]\]. CS proteins colocalize with and bind PCM1 and require PCM1 for their pericentrosomal localization, and distinct populations of CS exist comprised of different proteins \[[@bib15]\]. However, the functional significance of this is poorly understood.

Centrosomal GABARAP traffics to forming autophagosomes during starvation \[[@bib13]\]. Importantly, this demonstrates a centrosome-autophagosome crosstalk. How centrosomal proteins regulate the transport of GABARAP from the centrosome to autophagosomes and GABARAP-mediated autophagy is unknown. Here, we show that GABARAP, but not LC3B, directly binds to the CS protein PCM1 through a LIR motif. GABARAP is found on a subset of peripheral CS, and its localization at the centrosome is controlled by PCM1. PCM1 promotes the formation of GABARAP-positive (but not LC3B-positive) autophagosomes and colocalizes with autophagy markers. PCM1 protects GABARAP from proteasomal degradation mediated by ubiquitination by Mib1. These data suggest that PCM1-containing CSs stabilize centrosomal GABARAP and control its delivery to autophagosomes.

Results {#sec2}
=======

PCM1 Binds GABARAP through a LIR Motif {#sec2.1}
--------------------------------------

The CS protein PCM1 interacts with overexpressed LC3B, GABARAP, and GABARAPL2 (GATE-16) \[[@bib20], [@bib21]\]. In HEK293A cells, PCM1 co-immunoprecipitated with endogenous GABARAP ([Figure 1](#fig1){ref-type="fig"}A), and this complex is not affected by amino acid starvation to induce autophagosome formation ([Figure 1](#fig1){ref-type="fig"}B). PCM1-GFP-GABARAP interaction was independent of GABARAP lipidation as PCM1 bound equally to GFP-GABARAP and GFP-GABARAP G116A, a mutant which cannot be lipidated \[[@bib22]\], in fed, starved (ES), or starved cells treated with Bafilomycin A1 (BAFA1) to prevent lysosomal degradation of autophagosomes ([Figures 1](#fig1){ref-type="fig"}C and 1D). PCM1 bound ATG8 family members LC3C/GABARAP/GABARAPL1/GABARAPL2 but poorly to LC3A/LC3B ([Figure 1](#fig1){ref-type="fig"}E). We searched for LIR motifs in the 2,016aa human PCM1 protein (Refseq [NP_001302436](ncbi-p:NP_001302436){#intref0010}) using iLIR \[[@bib23]\]. One LIR motif (aa 1,953-EDFVKV-aa 1,958) near the C terminus of PCM1, within a region required to retain PCM1 at the centrosome \[[@bib24], [@bib25]\], is similar to the human ULK LIR motif (DDFVM/LV) \[[@bib26], [@bib27]\]. Mutation of the PCM1 LIR EDFVKV to EAAVKA (3xAla) reduced binding to glutathione S-transferase (GST)-GABARAP by more than 80% ([Figures 1](#fig1){ref-type="fig"}F and 1G). A mutational peptide array of the PCM1 LIR motif showed PCM1 has a canonical LIR motif that directly binds GST-GABARAP ([Figure 1](#fig1){ref-type="fig"}H). D1954, F1955, V1956, V1958, and P1962 were essential for LIR binding. This is based on the LIR core of 0(W/F/Y)xx(L/I/V)+3 with surrounding acidic residues \[[@bib28]\].Figure 1PCM1 Directly Binds GABARAP through a LIR Motif(A) Anti-GABARAP immunoprecipitation from HEK293A cells and immunoblot. Beads + Ab, anti-GABARAP antibody with protein G beads; beads + Lys, HEK293A lysate with protein G beads.(B) HEK293A cells in full medium (FM) or EBSS (ES) for 2 hr prior to lysis, followed by treatment as in (A).(C) HEK293A cells expressing indicated constructs in FM, ES, or EBSS + BAFA (EB) for 2 hr prior to lysis and GFP-TRAP. GFP-GABA, GFP-GABARAP; WT, wild-type.(D) Statistical analysis of (C); one-way ANOVA. NS, non-significant.(E) GFP-TRAP of HEK293A cells expressing the indicated GFP-ATG8 constructs and immunoblot.(F) HEK293A cells expressing the indicated GFP-tagged constructs incubated with GST or GST-GABARAP beads and immunoblotted. 3xAla, LIR mutant.(G) Statistical analysis of (F); unpaired Student's t test; mean ± SEM; n = 3. ^∗∗∗∗^p ≤ 0.0001.(H) 24-mer array of PCM1 peptides covering the LIR motif incubated with GST-GABARAP and immunoblot. Each amino acid position was substituted for every other amino acid.

PCM1 Colocalizes with GABARAP at the Pericentriolar Material and CSs {#sec2.2}
--------------------------------------------------------------------

We next tested whether PCM1-GABARAP colocalized in cells. In [Figure 2](#fig2){ref-type="fig"}A, we confirm GABARAP colocalizes with the centriole and pericentriolar material (PCM) marker γ-tubulin \[[@bib13]\]. GABARAP was on the PCM and not centrioles, as shown by correlative light and electron microscopy (CLEM) ([Figure S1](#mmc1){ref-type="supplementary-material"}). In cells where the PCM and centrioles were juxtaposed, GABARAP was on the PCM rather than centrioles ([Figure S1](#mmc1){ref-type="supplementary-material"}). In the electron microscopy (EM), the PCM is a round, amorphous, dense structure near the centrioles \[[@bib14]\]. We observed non-membrane-bound (Triton X-100 resistant) electron-dense granules (most likely CSs \[[@bib29]\]), surrounding and embedded in the PCM ([Figure S1](#mmc1){ref-type="supplementary-material"}). Concordantly, confocal microscopy revealed PCM1 partially overlapping with γ-tubulin, as expected ([Figure 2](#fig2){ref-type="fig"}A) \[[@bib29]\].Figure 2PCM1 and GABARAP Colocalize at the Centrosome and Peripheral CSs(A) HEK293A cells starved for 2 hr in EBSS, fixed and labeled with the mouse anti-PCM1, rabbit anti-GABARAP, and goat anti-gamma tubulin antibodies. The scale bars represent (top) 5 μm and (bottom) 2 μm. Arrowheads and insets show PCM1-GABARAP colocalization. ^∗^GABARAP-PCM1 at the PCM. Nuc, nucleus.(B) HEK293A cells starved for 2 hr in EBSS, fixed and labeled with the indicated antibodies. Pearson's correlation coefficient (PCC) was quantified between non-centrosomal GABARAP-PCM1 or GABARAP-p62 puncta, with and without PCM1 siRNA. Subcellular regions are quantified from two independent experiments.(C) HEK293A cells expressing myc-GABARAP, starved for 2 hr in EBSS, and then fixed and labeled with rabbit anti-PCM1, mouse anti-myc, and goat anti-SSX2IP antibodies; scale bar, 2 μm.(D) HEK293 Flp-In T-Rex cells stably expressing inducible GFP-GABARAP, starved for 2 hr in EBSS, were fixed and labeled with rabbit anti-pericentrin antibodies. The scale bar represents 2 μm. In (C) and (D), arrowheads show GABARAP colocalization with CS markers.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

PCM1 and GABARAP do not require γ-tubulin to colocalize. In mitotic cells, they colocalized to a γ-tubulin negative structure ([Figure S2](#mmc1){ref-type="supplementary-material"}A) but much less at the spindle poles \[[@bib13], [@bib30]\]. In addition, GABARAP and PCM1 colocalized on a small number of peripherally distributed γ-tubulin-negative CSs (PCM1 puncta) ([Figure 2](#fig2){ref-type="fig"}A). Small interfering RNA (siRNA) depletion of PCM1 reduced the staining of peripheral PCM1 puncta and centrosomal clusters of PCM1, with two different PCM1 antibodies used here for immunofluorescence ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Colocalization analysis revealed a positive correlation between non-centrosomal PCM1-GABARAP puncta, which was lost after PCM1 knockdown ([Figure 2](#fig2){ref-type="fig"}B). Note, a stronger correlation between p62-GABARAP puncta was observed ([Figure 2](#fig2){ref-type="fig"}B), as expected because p62 is contained within autophagosomes.

We investigated whether GABARAP colocalized with other CS markers. myc-GABARAP partially colocalized with the CS marker and PCM1 interactor SSX2IP ([Figure 2](#fig2){ref-type="fig"}C) \[[@bib31]\]. As expected, SSX2IP colocalized well with PCM1. GFP-GABARAP puncta partially colocalized with another PCM1 binding partner, pericentrin \[[@bib32]\] ([Figure 2](#fig2){ref-type="fig"}D).

These data suggest that PCM1 and GABARAP interact in the PCM and that GABARAP is a novel component of a subset of CSs.

CSs Are Delivered to Forming Autophagosomes {#sec2.3}
-------------------------------------------

Is PCM1, like GABARAP, recruited to autophagosomes? After 2 hr starvation to induce autophagy, a subset of PCM1-positive CSs colocalized with a range of autophagy markers: phagophore markers ATG9, ULK1 ([Figure S2](#mmc1){ref-type="supplementary-material"}C), DFCP1, and WIPI2; autophagosome marker LC3B; and cargo protein p62 ([Figures 3](#fig3){ref-type="fig"}A and 3B). GFP-WIPI2b-positive phagophores contained PCM1 and GABARAP ([Figure 3](#fig3){ref-type="fig"}A). Interestingly, some PCM1 puncta were juxtaposed to ring-shaped GFP-DFCP1 omegasomes ([Figure 3](#fig3){ref-type="fig"}B). To confirm PCM1 is on early autophagosomes, we immunoisolated GFP-DFCP1-positive membranes. In addition to autophagy proteins ULK1 and GABARAP, CS proteins PCM1 and Mib1 \[[@bib17], [@bib18]\] associated with GFP-DFCP1 membranes ([Figure 3](#fig3){ref-type="fig"}C). Thus, PCM1-GABARAP-positive CSs are associated with autophagic structures and may be involved in autophagosome formation.Figure 3CSs Are Found at Sites of Autophagosome Formation(A) HEK293A cells stably expressing GFP-WIPI2b starved for 2 hr in EBSS, fixed and labeled with mouse anti-PCM1 and rabbit anti-GABARAP antibodies. The scale bars represent 5 μm. Arrows indicate triple colocalization; arrowhead indicates GABARAP-PCM1 double colocalization.(B) HEK293A cells, or MEF cells stably expressing GFP-DFCP1, starved for 2 hr in EBSS, fixed and labeled with the indicated antibodies. The scale bars represent 5 μm. Arrows indicate colocalization or points of contact (GFP-DFCP1) between PCM1 and autophagy markers. Hoechst DNA staining is shown in blue in the merge. In all panels, rabbit anti-PCM1 antibody was used; mouse anti-WIPI2 or LC3B and guinea pig anti-p62 antibodies were used in the remaining panels.(C) HEK293 cells stably expressing GFP-DFCP1 starved for 2 hr in EBSS followed by immunoisolation with control immunoglobulin G (IgG) or anti-GFP and immunoblot analysis with the indicated antibodies.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

PCM1 Promotes GABARAP Centrosomal Localization {#sec2.4}
----------------------------------------------

PCM1-positive CSs are involved in recruiting proteins to the centrosome \[[@bib15]\]. PCM1 knockdown resulted in highly significant (p ≤ 0.0001) reduction of GABARAP at the PCM ([Figures 4](#fig4){ref-type="fig"}A, 4B, and [S3](#mmc1){ref-type="supplementary-material"}A) and a small increase in γ-tubulin. Centrosomal pericentrin was also reduced upon PCM1 depletion ([Figure S3](#mmc1){ref-type="supplementary-material"}B), as reported \[[@bib25]\]. Whereas no large frequency shifts in the brightness of γ-tubulin signals occurred upon PCM1 depletion, there was an increase in the number of centrosomes with weak GABARAP signal ([Figure S3](#mmc1){ref-type="supplementary-material"}A).Figure 4PCM1 Controls GABARAP Localization at the PCM, CS, and GABARAP Autophagosome Formation(A) HEK293A cells were treated with RISC free (RF) or PCM1 siRNA for 72 hr, fixed, and labeled with the mouse anti-PCM1, rabbit anti-GABARAP, and goat anti-gamma tubulin antibodies. The scale bar represents 20 μm.(B) Quantification of (A). Signal intensities at the pericentriolar material (γ-tubulin positive structures) were quantified and normalized to RF. Each measurement represents one centrosome. Statistical analysis using Mann-Whitney test; mean ± SEM; data from three independent experiments. ^∗∗∗∗^p ≤ 0.0001.(C) HEK293A cells expressing GFP-PCM1 WT or 3xAla LIR mutant starved for 2 hr in EBSS, fixed, and labeled with rabbit anti-GABARAP and mouse anti-WIPI2 antibodies. The scale bars represent 2 μm. Arrowheads, triple colocalization; arrows, GABARAP-WIPI2 colocalization. ^∗^PCM1 and GABARAP at the PCM.(D) HEK293A cells expressing GFP-PCM1 were treated with 50 μM nocodazole for 5 hr in total and starved for 2 hr in EBSS prior to fixation and labeling with rabbit anti-GABARAP and mouse anti-GM130 antibodies. Arrowheads, GFP-PCM1-GABARAP colocalization; arrows, GM130-GABARAP colocalization. ^∗^GABARAP at PCM. The scale bar represents 2 μm.(E) HEK293A cells were treated with RF or PCM1 siRNA for 72 hr and then incubated in ES or in ES with bafilomycin A1 (EB) for 2 hr, fixed, and labeled with the indicated antibodies before confocal microscopy and quantification of intracellular puncta. Statistical analysis using unpaired Student's t test; mean ± SEM; ^∗^p ≤ 0.05. Number of independent experiments: WIPI2, three; GABARAP, five; p62, three; and LC3, two.(F) HEK293A cells were treated with RF or PCM1 siRNA for 72 hr and then incubated in EBSS for 2 hr and fixed before confocal microscopy and quantification of intracellular GABARAP-p62 double-positive puncta. Mean ± SEM two independent experiments.(G) HEK293A cells expressing the indicated constructs were incubated in ES or in EB for 2 hr, fixed, and labeled with the indicated antibodies before confocal microscopy and quantification of intracellular puncta. Statistical analysis using unpaired Student's t test; mean ± SEM; ^∗∗^p ≤ 0.01. Three independent experiments.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

Does PCM1-GABARAP colocalization require the LIR motif of PCM1 ([Figures 1](#fig1){ref-type="fig"}F--1H)? Overexpression of GFP-PCM1 wild-type (WT) revealed GFP-PCM1 at the GABARAP-positive PCM as expected ([Figure 4](#fig4){ref-type="fig"}C). Peripheral GFP-PCM1 structures were positive for GABARAP and WIPI2. GFP-PCM 3xAla also localized at the PCM with GABARAP; however, peripheral GABARAP-WIPI2 puncta were negative for GFP-PCM1 3xAla ([Figure 4](#fig4){ref-type="fig"}C). In contrast, peripheral non-centrosomal puncta of both GFP-PCM1 WT and 3xAla colocalized with the PCM1-interactor pericentrin ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Thus, the C-terminal LIR of PCM1 is required for GABARAP (but not pericentrin) recruitment to GFP-PCM1 puncta. These data suggest GABARAP is recruited to CS by PCM1 binding and PCM1 is involved in recruitment of GABARAP to the PCM.

CS GABARAP Is Not Golgi Associated {#sec2.5}
----------------------------------

We showed that GABARAP binds the *cis*-Golgi protein GM130 \[[@bib13]\]. Upon nocodazole treatment to depolymerize microtubules and disperse the Golgi away from the centrosome, GABARAP was on peripheral GM130 puncta \[[@bib13]\]. We used nocodazole to disperse the Golgi and centrosomal CSs and found little colocalization between GM130 and GFP-PCM1 puncta ([Figure S3](#mmc1){ref-type="supplementary-material"}D). We observed partial colocalization between GFP-PCM1-GABARAP and GABARAP-GM130 ([Figure 4](#fig4){ref-type="fig"}D), but very few structures were positive for all three proteins. These data suggest that Golgi-associated GABARAP is separate from CS-associated GABARAP.

PCM1 Regulates GABARAP Degradation and Autophagy {#sec2.6}
------------------------------------------------

A subpopulation of PCM1-positive CSs are at autophagosome formation sites ([Figures 3](#fig3){ref-type="fig"} and [S2](#mmc1){ref-type="supplementary-material"}C). To determine whether PCM1 depletion affects autophagosome formation, starvation-induced WIPI2, GABARAP, LC3B, and p62 puncta were counted in HEK293A cells ([Figures 4](#fig4){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}). Whereas WIPI2, GABARAP, and p62 puncta were increased after PCM1 knockdown, no significant effect on LC3B puncta was seen. Moreover, the number of GABARAP-p62 double-positive autophagosomes increased ([Figure 4](#fig4){ref-type="fig"}F). This suggests PCM1 regulates GABARAP-positive autophagosome formation.

Plk4 promotes phosphorylation of PCM1 at S372 \[[@bib33]\]. S372 phosphorylation, which occurs during G1 of the cell cycle, promotes PCM1 dimerization and interaction with CS proteins. Compared to WT, PCM1 S372E phosphomimetic mutant exhibits reduced CS motility and increased clustering, whereas the S372A mutant has a more dispersed phenotype \[[@bib33]\]. To determine whether this regulatory phosphorylation exerts an effect on GABARAP autophagosome formation, we expressed GFP-PCM1 WT, GFP-PCM1 S372A, or S372E and measured the formation of GABARAP-WIPI2 double-positive autophagosomes with BAFA1 present to prevent lysosomal degradation of autophagosomes. The number of GABARAP-WIPI2-positive autophagosomes was attenuated when PCM1 S372 was mutated to either E/A ([Figure 4](#fig4){ref-type="fig"}G). This suggests PCM1 S372 is important for GABARAP autophagosome formation and perhaps regulated by reversible phosphorylation events.

PCM1 is not required for rapamycin-induced autophagy \[[@bib21]\]. Concordantly, PCM1 knockdown had no effect on LC3B lipidation or flux through the lysosome as measured by accumulation of lipidated LC3B (LC3-II) in the presence of BAFA1 ([Figures 5](#fig5){ref-type="fig"}A and 5B). PCM1 levels were not altered by autophagy, as there was no change in Earle's balanced salt solution (EBSS) compared to EBSS with BAFA1 ([Figures 5](#fig5){ref-type="fig"}A and 5B). However, we observed a decrease in both unlipidated and lipidated GABARAP (GABARAP-I and GABARAP-II, respectively), indicating a total decrease in GABARAP protein levels ([Figures 5](#fig5){ref-type="fig"}C--5E). Autophagy cargoes p62 and NBR1 were also decreased ([Figures 5](#fig5){ref-type="fig"}A and 5B). In addition, p62 and GABARAP protein levels increased upon GFP-PCM1 overexpression ([Figures 5](#fig5){ref-type="fig"}F and 5G). This suggests a specific effect of the PCM1 protein on GABARAP/p62 protein levels.Figure 5PCM1 Specifically Regulates GABARAP Protein Levels through Its LIR Motif(A) HEK293A cells treated with RF or PCM1 siRNA incubated in full medium (FM) or EBSS with or without BAFA for 2 hr.(B) Quantifications from (A). For LC3-II/actin, n = 3. For p62/actin, n = 5. For NBR1/actin, n = 5. For PCM1/actin, n = 5. Mean ± SEM. One-way ANOVA; ^∗^p ≤ 0.05.(C and D) HEK293A cells treated with RF or PCM1 siRNA incubated in FM or EBSS with or without BAFA1 for 2 hr. In (C), GABARAP-I and GABARAP-II are resolved, whereas in (D) only GABARAP-I is resolved in the western blot.(E) Quantifications from (C) and (D). For GABARAP-II/actin, n = 5. For GABARAP-I/actin, n = 3. Mean ± SEM. One-way ANOVA; ^∗^p ≤ 0.05.(F) HEK293A cells expressing the indicated constructs were subjected to immunoblot.(G) Quantification of (F). For p62/actin, n = 4. For GABARAP-I/actin, n = 5. Mean ± SEM; unpaired Student's t test; ^∗∗^p ≤ 0.01.(H) HEK293A cells treated with RF or PCM1 siRNA (72 hr total) and transfected with the indicated siPCM1-resistant constructs (last 24 hr) and immunoblotted.(I) Quantifications from (H). For RF+GFP, siPCM1+GFP, and siPCM1+GFP-PCM1 WT, six experiments are shown. For siPCM1+GFP-PCM1 3xAla, three experiments are shown. Mean ± SEM; unpaired Student's t test; ^∗∗^p ≤ 0.01.

The LIR motif in PCM1 binds to ([Figures 1](#fig1){ref-type="fig"}F--1H) and localizes GABARAP ([Figure 4](#fig4){ref-type="fig"}C) to CS. We asked whether the LIR motif was also required for the stabilization of GABARAP seen after overexpression of GFP-PCM1. After siRNA depletion of PCM1, GABARAP levels were rescued by expression of GFP-PCM1 WT, but not by GFP-PCM1 3xAla ([Figures 5](#fig5){ref-type="fig"}H and 5I). These data suggest that direct binding of PCM1 to GABARAP stabilizes GABARAP protein levels.

We assessed the degradation rate of GABARAP in PCM1 knockout cells ([Figures 6](#fig6){ref-type="fig"}A and 6B). In single-guide (sgRNA) control RPE-1 cells, more than 50% of GABARAP remained during 8 hr cycloheximide treatment to inhibit translation. Without PCM1, the rate of GABARAP degradation was enhanced, suggesting that PCM1 stabilizes GABARAP. PCM1-controlled GABARAP degradation may occur through the proteasomal or lysosomal pathways. In HEK293A cells, we combined cycloheximide treatment with MG132, an inhibitor of the proteasome, or BAFA1 ([Figures 6](#fig6){ref-type="fig"}C and 6D). Proteasomal inhibition was confirmed by the accumulation of polyubiquitinated proteins after MG132 treatment ([Figure 6](#fig6){ref-type="fig"}C). Surprisingly, GABARAP turnover is inhibited by MG132 or BAFA1, suggesting that the proteasome degrades GABARAP to a similar extent as autophagy during basal conditions. However, after PCM1 depletion, significantly more GABARAP was degraded through the proteasome than the lysosome ([Figure 6](#fig6){ref-type="fig"}D). Altogether, these data suggest PCM1 specifically regulates GABARAP autophagosome formation and autophagic flux of cargoes and stabilizes GABARAP from proteasomal degradation.Figure 6PCM1 Regulates GABARAP Proteasomal Degradation(A) Control or PCM1 knockout RPE-1 cells were subjected to cycloheximide (CHX) treatment for the indicated number of hours prior to immunoblotting.(B) Quantification of (A). Mean ± SEM; n = 3; unpaired Student's t test; ^∗^p ≤ 0.05.(C) HEK293A cells treated with RF or PCM1 siRNA were incubated in DMSO, cycloheximide (CHX), MG132 (MG), and/or bafilomycin A1 (BAFA1) for 8 hr.(D) Quantification of (C). Mean ± SEM; n = 3; one-way ANOVA; ^∗^p ≤ 0.05.

GABARAP Instability and Ubiquitination Is Driven by Mib1 {#sec2.7}
--------------------------------------------------------

PCM1 binds and stabilizes GABARAP from proteasomal degradation, and this may occur at the PCM, CS, and sites of autophagosome formation ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}). PCM1 sequesters the CS E3 ligase Mib1 \[[@bib17], [@bib18]\]. PCM1 depletion results in increased Mib1 levels and relocalization of Mib1 from CS to centrioles, where it ubiquitinates and destabilizes centrosomal proteins \[[@bib17]\]. In HEK293A cells, Mib1 protein levels increased after PCM1 depletion, as expected, concomitant with a decrease in GABARAP and p62 levels ([Figure S5](#mmc1){ref-type="supplementary-material"}A). FLAG-Mib1 expression decreased PCM1 levels as expected \[[@bib17]\] but also GABARAP levels, suggesting that Mib1 interacts with GABARAP ([Figures 7](#fig7){ref-type="fig"}A and 7B). Mib1 bound to GST-GABARAP, and FLAG-Mib1 co-immunoprecipitated with GABARAP ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). Additionally, endogenous Mib1 and GABARAP co-immunoprecipitated ([Figure 7](#fig7){ref-type="fig"}C). GST-GABARAP bound both WT FLAG-Mib1 and catalytically inactive Mib1 ([Figure S5](#mmc1){ref-type="supplementary-material"}D). By mapping experiments, GST-GABARAP interacted with aa 1--429 of Mib1 ([Figure 7](#fig7){ref-type="fig"}D), which contains the N-terminal zinc finger ([Figure S5](#mmc1){ref-type="supplementary-material"}E). Substrates of Mib1-mediated ubiquitination are known to interact with this region \[[@bib34], [@bib35]\].Figure 7Mib1 E3 Ligase Interacts with and Destabilizes GABARAP and Promotes GABARAP Ubiquitination at Lys13 and Lys23(A) HEK293A cells expressing FLAG-Mib1 or control vector for 48 hr were analyzed by immunoblot.(B) Quantification of (A). Statistical analysis using unpaired Student's t test; mean ± SEM; n = 3; ^∗^p ≤ 0.001.(C) Anti-GABARAP immunoprecipitate from HEK293A cells analyzed by immunoblotting. Ab, anti-GABARAP antibody. Lys, HEK293A lysate.(D) HEK293A cells expressing FLAG-tagged constructs were incubated with recombinant GST or GST-GABARAP beads and immunoblotted.(E) GFP-TRAP of HEK293A cells expressing the indicated constructs and immunoblot. Immunoprecipitates were stringently washed in denaturing buffer. CS, C985S; GAB, GABARAP; Ponc, Ponceau S. Short and long exposures are shown. ^∗^, ^∗∗^, ^∗∗∗^, mono-, di-, and tri-ubiquitinated GFP-GABARAP, respectively.(F) Immunoprecipitation of U2OS cells expressing the indicated constructs lysed in boiling SDS buffer and immunoblot. Free ubiquitin and ^∗^, ^∗∗^, ^∗∗∗^, mono-, di-, and tri-ubiquitinated GFP-LC3B/GABARAP are indicated, respectively.(G) GFP-TRAP of HEK293A cells expressing the indicated constructs and immunoblot. Immunoprecipitates were washed as in (E).(H) See (G). Low and high exposures are shown.(I) Immunoprecipitation of HEK293A cells expressing the indicated constructs and immunoblot. Cells were treated with MG132 for 5 hr prior to lysis in TNTE buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 0.5% w/v Triton X-100, 5 mM EDTA) + N-ethylmaleimide. Diubiquitinated GABARAP is indicated with ^∗∗^. Immunoglobulin light chain is indicated with an arrow.(J) Immunoprecipitation of HEK293A cells treated with RF or GABARAP siRNA for 72 hr and expressing the indicated constructs and immunoblot. Cells were treated with MG132 for 5 hr prior to lysis in TNTE buffer + N-ethylmaleimide. Di- and tri-ubiquitinated GABARAP is indicated with ^∗∗^ and ^∗∗∗^, respectively. Immunoglobulin light chain is indicated with an arrow.(K) Two GABARAP ubiquitination sites, lysine 13 (K13) and lysine 23 (K23), were identified by mass spectrometry on three different peptides. (Top) Comparison of peak areas for the FVYKEEHPFEK(diGly)R peptide containing K13 ubiquitination site (n = 3 measurements) is shown. (Middle and bottom) The K23 ubiquitination site was detected as two different peptides as a result of missed cleavage. Quantification of peptides K(diGly)KYPDRVPVIVEK (middle) and K(diGly)KYPDR (bottom) showed significantly lower abundance in C985S mutant compared to the WT.(L) Conservation of GABARAP K13 and K23 (^∗^) between ATG8 orthologs.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

We next investigated whether Mib1 promotes GABARAP ubiquitination. Mib1 promoted the mono-, di-, tri-, and poly-ubiquitination of GFP-GABARAP ([Figures 7](#fig7){ref-type="fig"}E, [S5](#mmc1){ref-type="supplementary-material"}F, and S5G). GFP-GABARAP was more readily ubiquitinated than GFP-LC3B ([Figure 7](#fig7){ref-type="fig"}F). We confirmed GFP-GABARAP mono-, di-, tri-, and poly-ubiquitination with an anti-ubiquitin antibody after washing immunoprecipitated GFP-GABARAP with denaturing 8 M urea and 1% SDS ([Figure 7](#fig7){ref-type="fig"}G). Mib1 promotes both K48- and K63-linked ubiquitination \[[@bib36], [@bib37]\]. Di-, tri-, and poly-ubiquitination of GFP-GABARAP occurred through K48-linked ([Figure 7](#fig7){ref-type="fig"}H), but not K63-linked, ubiquitination ([Figure S5](#mmc1){ref-type="supplementary-material"}H). K48 ubiquitin linkages are often associated with proteasomal degradation \[[@bib38]\]. Large polyubiquitinated GFP-GABARAP conjugates (\>300 kDa) were detected as K63 linked ([Figure S5](#mmc1){ref-type="supplementary-material"}H). We detected a small population of di- and tri-ubiquitinated endogenous GABARAP ([Figures 7](#fig7){ref-type="fig"}I and 7J). Moreover, di- and tri-ubiquitinated GABARAP was depleted by GABARAP siRNA, suggesting that these were conjugates of GABARAP ([Figure 7](#fig7){ref-type="fig"}J). Finally, mass spectrometry revealed FLAG-Mib1-driven ubiquitination of GFP-GABARAP occurs at lysine 13 and 23 ([Figures 7](#fig7){ref-type="fig"}K, 7L and [S5](#mmc1){ref-type="supplementary-material"}I--S5K).

Discussion {#sec3}
==========

Many organelles/structures regulate the formation of the autophagosome \[[@bib21], [@bib39], [@bib40], [@bib41], [@bib42]\]. The (non-ciliated) centrosome also appears to regulate autophagy \[[@bib13]\]. Here, we describe a role for CS in autophagy regulation, giving insight into the function and regulation of the enigmatic centrosomal pool of GABARAP and centrosome-autophagosome communication.

Our data suggest GABARAP is a novel component of a subset of CSs. CSs are not a homogeneous population, and whereas they have established functions, for example in ciliogenesis, the role of different types of CSs is poorly understood \[[@bib15]\]. This study implicates PCM1-GABARAP-positive CSs in delivery to autophagosomes and autophagy regulation. We favor a model whereby GABARAP bound to CS is delivered to forming autophagosomes to perform its autophagic function. This is supported by our work showing delivery of centrosomal GABARAP to pre-existing autophagic structures upon starvation \[[@bib13]\].

The role of basal autophagy in ciliogenesis in dividing cells is thought to be to degrade ciliogenesis activators (IFT20 and IFT88) \[[@bib41], [@bib43]\]. However, in non-dividing cells serum starved for 24 hr, the inhibitor of ciliogenesis, OFD1, a CS protein, is degraded by autophagy, but PCM1 is not \[[@bib21]\]. In addition, we found that the slight decrease in PCM1 protein levels seen after 2 hr of amino acid starvation is not increased by bafilomycin A1 treatment ([Figure 5](#fig5){ref-type="fig"}B). Furthermore, the PCM1-GABARAP interaction is independent of amino acid levels ([Figures 1](#fig1){ref-type="fig"}B--1D). It is likely that GABARAP-PCM1 CS localization at autophagosomes is separate from ciliogenesis, as PCM1 colocalization with autophagosome markers was seen during 2 hr starvation, a timescale too short for significant primary cilia formation \[[@bib44]\]. In addition, we found no evidence for a requirement of GABARAP for cilia formation (data not shown). However, we do not rule out the possibility that multiple ATG8 proteins act redundantly in ciliogenesis.

CSs are transported along microtubules \[[@bib19], [@bib25], [@bib29]\], which could explain how GABARAP at the pericentriolar material could be transferred to distal forming autophagosomes. By immunofluorescence microscopy, GABARAP is enriched within the PCM compared to the adjacent CS. This is disrupted upon PCM1 knockdown ([Figures 4](#fig4){ref-type="fig"}A, 4B, and [S3](#mmc1){ref-type="supplementary-material"}A). We also saw structures reminiscent of CSs embedded in the PCM by CLEM ([Figure S1](#mmc1){ref-type="supplementary-material"}). Combined with the role of PCM1 in enhancing GABARAP stability ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), we propose that CSs regulate the recruitment and stabilization of GABARAP at the PCM.

PCM1 depletion has no effect on autophagy, as measured by LC3 lipidation alone ([Figures 5](#fig5){ref-type="fig"}A and 5B) \[[@bib21]\]. However, PCM1 binds very weakly to LC3B in comparison to GABARAP ([Figure 1](#fig1){ref-type="fig"}E). PCM1-GABARAP binding is mediated through a canonical ULK-type LIR motif ([Figures 1](#fig1){ref-type="fig"}F--1H). PCM1 depletion results in destabilization of GABARAP, but not LC3B, and a reduction of proteins degraded by autophagy (p62 and NBR1) ([Figures 5](#fig5){ref-type="fig"}A--5E, [6](#fig6){ref-type="fig"}A, and 6B). In addition, more GABARAP-positive autophagosomes are formed after PCM1 depletion, but LC3B-positive autophagosomes are unaffected ([Figures 4](#fig4){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}). Based on our data, we suggest that GABARAP is held in an inactive (non-autophagic) state through direct binding to the PCM1 LIR motif on CSs. This would prevent GABARAP from recruiting LIR-containing proteins \[[@bib11]\] or LIR-containing ATG proteins, such as ULK1 \[[@bib13]\]. However, these CSs can be sent to forming autophagosomes to function in autophagy when required. In addition, stabilization and recruitment of GABARAP by CSs to the PCM maintains a reservoir of unlipidated non-autophagic GABARAP at the centrosome \[[@bib13]\]. This pool is poised to contribute to autophagosome formation upon starvation. How this is fully regulated and the importance or function of centrosomal GABARAP remains to be demonstrated. In the absence of PCM1, GABARAP is destabilized through Mib1 activity ([Figures 7](#fig7){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}) and GABARAP is released from PCM1, freeing up its LIR-binding pocket. This dysregulated GABARAP could then readily form autophagosomes, resulting in enhanced p62 and NBR1 degradation. Interestingly, Mib1 relocalizes from CSs to centrioles after PCM1 depletion \[[@bib17]\], which places Mib1 in proximity for GABARAP ubiquitination.

This study contributes to efforts in the autophagy field to understand why ATG8 has undergone divergent evolution from yeast to human and the functional/regulatory differences between the six orthologs. Recently, GABARAPs, but not LC3s, were shown to be required for starvation-induced autophagy and also mitophagy \[[@bib7], [@bib45]\]. The full role of GABARAP-enriched autophagosomes is not known. Perhaps PCM1 has a role in GABARAP-specific autophagy, such as in damaged mitochondrial clearance.

Surprisingly, we found that GABARAP is efficiently degraded through both the proteasome and lysosome ([Figures 6](#fig6){ref-type="fig"}A--6D). The rate of GABARAP turnover in RPE-1 cells was enhanced in the absence of PCM1 ([Figures 6](#fig6){ref-type="fig"}A and 6B). In HEK293A cells, GABARAP is constitutively turned over, and proportionately more GABARAP is degraded through the proteasome than the lysosome upon PCM1 depletion ([Figures 6](#fig6){ref-type="fig"}C and 6D). Nonetheless, we saw an increase of GABARAP-positive autophagosomes by immunofluorescence microscopy ([Figures 4](#fig4){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}), suggesting increased autophagosome formation.

GABARAP was thought to not be degraded by the proteasome \[[@bib46]\]; however, recently, ATG4B binding GABARAP through a LIR motif was shown to stabilize GABARAP from proteasomal degradation \[[@bib47]\]. As PCM1 also regulates GABARAP protein levels through a LIR motif ([Figures 5](#fig5){ref-type="fig"}H and 5I), perhaps LIR binding to GABARAP is a general mechanism of stabilization. The PCM1-binding CS E3 ligase Mib1 \[[@bib17], [@bib18]\], which is no longer sequestered by PCM1 after PCM1 depletion, destabilizes GABARAP, most likely through K48-linked ubiquitination of GABARAP, which probably occurs at K13 and K23. In support, ubiquitination of endogenous GABARAP at K13 and K23 has been reported using mass spectrometry \[[@bib48]\]. Our data suggest this destabilization occurs through proteasomal degradation of GABARAP. Interestingly, LC3B is a much poorer target for ubiquitination promoted by Mib1 than GABARAP ([Figure 7](#fig7){ref-type="fig"}F). This could be related to preferential binding of GABARAP to PCM1 and GABARAP localization to the pericentriolar material, both of which would bring GABARAP in proximity to Mib1. The ubiquitination of GABARAP within an N-terminal helix is also interesting, as this region is less well conserved between ATG8 orthologs (see [Figure 7](#fig7){ref-type="fig"}L, and \[[@bib6]\]), and so ubiquitination at these sites may provide a method of specific regulation of ATG8s.

In conclusion, our results shed light on the role of CSs in centrosomal regulation of starvation-induced autophagy. We hypothesize that the centrosomal pool of GABARAP may be a storage pool. At resting state, autophagy proteins are already translated and poised to act during acute autophagy stimulation. Whereas several core autophagy proteins exert non-autophagic functions \[[@bib49]\], it may be that their preservation at a resting state location facilitates rapid autophagosome formation induced by an acute signal, such as amino acid starvation.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse anti-VinculinSigma-AldrichCat\#V9264; RRID: [AB_10603627](nif-antibody:AB_10603627){#intref0015}Mouse anti-GABARAP, for IPMBL InternationalCat\#M135-3; RRID: [AB_10364779](nif-antibody:AB_10364779){#intref0020}Mouse anti-LC3, for IF (Clone 5F10)NanoToolsCat\#0231-100/LC3-5F10Mouse anti-GM130, for IFBD BiosciencesCat\#610822; RRID: [AB_398141](nif-antibody:AB_398141){#intref0025}Mouse anti-PCM1, for WBAtlas AntibodiesCat\#AMAb90565Mouse anti-PCM1, for IFSigma-AldrichCat\#SAB1406228; RRID: [AB_10738915](nif-antibody:AB_10738915){#intref0030}Mouse anti-Ubiquitin (Clone FK2)MBL InternationalCat\#D058-3; RRID: [AB_592937](nif-antibody:AB_592937){#intref0035}Mouse anti-γ-tubulin ascites (Clone GTU-88)Sigma-AldrichCat\#T6557; RRID: [AB_477584](nif-antibody:AB_477584){#intref0040}Mouse anti-p62/SQSTM1BD BiosciencesCat\#610832; RRID: [AB_398151](nif-antibody:AB_398151){#intref0045}Mouse anti-p62/SQSTM1Abnova CorporationCat\#H00008878-M01; RRID: [AB_437085](nif-antibody:AB_437085){#intref0050}Mouse anti-FLAG (Clone M2)Sigma-AldrichF3165Mouse anti-WIPI2\[[@bib50]\]N/AMouse anti-GFP (Clone 3E1)Raised in-house, Cancer Research UKN/ARabbit anti-PericentrinAbcamCat\#ab4448; RRID: [AB_304461](nif-antibody:AB_304461){#intref0055}Rabbit anti-Mib1Sigma-AldrichCat\#M5948; RRID: [AB_1841007](nif-antibody:AB_1841007){#intref0060}Rabbit anti-Ubiquitin Lys48-specific (Clone APU2)MilliporeCat\#05-1307; RRID: [AB_1587578](nif-antibody:AB_1587578){#intref0065}Rabbit anti-ubiquitin Lys63-specific (Clone APU3)MilliporeCat\#05-1308; RRID: [AB_1587580](nif-antibody:AB_1587580){#intref0070}Rabbit anti-PCM1, for IFCell Signaling TechnologyCat\#5213S; RRID: [AB_10556960](nif-antibody:AB_10556960){#intref0075}Rabbit anti-ULK1 (H-240), for WBSanta Cruz BiotechnologyCat\#sc-33182; RRID: [AB_2214706](nif-antibody:AB_2214706){#intref0080}Rabbit anti-ULK1 (D8H5), for IFCell Signaling TechnologyCat\#8054; RRID: [AB_11178668](nif-antibody:AB_11178668){#intref0085}Rabbit anti-GABARAPAbgentCat\#AP1821a; RRID: [AB_2278762](nif-antibody:AB_2278762){#intref0090}Rabbit anti-NBR1Cell Signaling TechnologyCat\#9891S; RRID: [AB_10949888](nif-antibody:AB_10949888){#intref0095}Rabbit anti-HACovance Research Products IncCat\#PRB-101 also PRB-101P-500, PRB-101C-500, PRB-101C-200, PRB-101P-200; RRID: [AB_291552](nif-antibody:AB_291552){#intref0100}Rabbit anti-WIPI2\[[@bib50]\]N/ARabbit anti-ActinAbcamCat\#ab8227; RRID: [AB_2305186](nif-antibody:AB_2305186){#intref0105}Rabbit anti-LC3BAbcamCat\#ab48394; RRID: [AB_881433](nif-antibody:AB_881433){#intref0110}Hamster anti-ATG9\[[@bib51]\]N/AGuinea pig anti-p62Progen BiotechnikCat\#GP62-CGoat anti-SSX2IPThermo Fisher ScientificCat\#PA5-18258; RRID: [AB_10985892](nif-antibody:AB_10985892){#intref0115}Goat anti-γ-tubulin (C-20)Santa Cruz BiotechnologyCat\#sc-7396; RRID: [AB_2211262](nif-antibody:AB_2211262){#intref0120}Mouse TrueBlot ULTRA: Anti-Mouse Ig HRPRockland ImmunochemicalsCat\#18-8817-31; RRID: [AB_2610850](nif-antibody:AB_2610850){#intref0125}Rabbit TrueBlot: Anti-Rabbit IgG HRPRockland ImmunochemicalsCat\#18-8816-31; RRID: [AB_2610847](nif-antibody:AB_2610847){#intref0130}Anti-GST HRP ConjugateGE HealthcareCat\#RPN1236; RRID: [AB_771429](nif-antibody:AB_771429){#intref0135}GFP-Trap_AChromoTekCat\#gta-20; RRID: [AB_2631357](nif-antibody:AB_2631357){#intref0140}Anti-HA Affinity Matrix (Clone 3F10)Sigma-AldrichCat\#000000011815016001; RRID: [AB_390914](nif-antibody:AB_390914){#intref0145}**Bacterial and Virus Strains***E. coli* BL21-CodonPlus(DE3)-RILAgilentCat\#230245**Chemicals, Peptides, and Recombinant Proteins**Lipofectamine 2000 transfection reagentThermo Fisher ScientificCat\#11668019Bafilomycin A1Merck MilliporeCat\#196000MG132Merck MilliporeCat\#474790ChloroacetamideSigma-AldrichCat\#C0267NocodazoleSigma-AldrichCat\#M1404PhosSTOPSigma-AldrichCat\#000000004906845001SignalBoostImmunoreaction Enhancer KitMerck MilliporeCat\#407207Luminata Crescendo Western HRP substrateMerck MilliporeCat\#WBLUR0100Protein G SepharoseSigma-AldrichCat\#P3296-1MLGlutathione Sepharose 4BGE HealthcareCat\#17075601Dynabeads Protein A for ImmunoprecipitationThermo Fisher ScientificCat\#10001DN-EthylmaleimideSigma-AldrichCat\#E3876Recombinant protein: GSTThis paperN/ARecombinant protein: GST-GABARAPThis paperN/AcOmplete, EDTA-free Protease Inhibitor CocktailSigma-AldrichCat\#000000005056489001**Critical Commercial Assays**QuikChange Multi Site-Directed Mutagenesis KitAgilentCat\#200515Q5 Site-Directed Mutagenesis KitNew England BioLabsCat\#E0554S**Deposited Data**The protein interactions from this publication have been submitted to the IMEx (<http://www.imexconsortium.org>) consortium through IntAct \[[@bib52]\]This paperIM-25779**Experimental Models: Cell Lines**Human: HEK293A cellsThermo Fisher ScientificCat\#R70507**Oligonucleotides**siRNA targeting sequence RISC Free controlDharmaconCat\#D-001220-01siRNA targeting sequence human GABARAP: GGUCAGUUCUACUUCUUGADharmaconCat\#D-012368-02siRNA targeting sequence human PCM1: GCAAAUAGAUCAUCAGAAADharmaconCat\#D-005165-01Primer: PCM1 SDM Primer 3xAla, CTG GTA ATA TAA GTC AAA AGT CTG ATG AAG AAG CTG CTG TAA AAG CTG AAG ATT TAC CAC TGA AAC TGA CAA TAT ATT CThis paper, see [Method Details](#sec4.4){ref-type="sec"}N/APrimer: PCM1 SDM Primer siRNA resistant Forward, CGT CGG AAA AGA ATA AGA AAA AGT TTG GTG TAGThis paper, see [Method Details](#sec4.4){ref-type="sec"}N/APrimer: PCM1 SDM Primer siRNA resistant Reverse, ACC TGT TCG CTT TCT TCT GTT GGG CAC CThis paper, see [Method Details](#sec4.4){ref-type="sec"}N/A**Recombinant DNA**pLVX-IRES-PURO 3xFLAG\[[@bib17]\]N/ApLVX-IRES-PURO 3xFLAG-Mib1\[[@bib17]\]N/ApLVX-IRES-PURO 3xFLAG-Mib1 C985S\[[@bib17]\]N/ApcDNA3 FLAG-Mib1\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 C997S\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 aa1-729\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 aa730-1007\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 aa1-429\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 aa430-1007\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 aa430-729\[[@bib34]\]N/ApcDNA3 FLAG-Mib1 aa820-1007\[[@bib34]\]N/ApEGFP C2 PCM1\[[@bib33]\]N/ApEGFP C2 PCM1 S372A\[[@bib33]\]N/ApEGFP C2 PCM1 S372E\[[@bib33]\]N/ApDEST EGFP-LC3ATerje JohansenN/ApDEST EGFP-LC3BTerje JohansenN/ApDEST EGFP-LC3CTerje JohansenN/ApDEST EGFP-GABARAPTerje JohansenN/ApDEST EGFP-GABARAPL1Terje JohansenN/ApDEST EGFP-GABARAPL2Terje JohansenN/ApDEST-myc-GABARAPTerje JohansenN/ApDEST-EGFP-GABARAP G116A\[[@bib13]\]N/ApGEX-5X-1 GST-GABARAPZvulun ElazarN/A**Software and Algorithms**ImageJNIH<https://imagej.nih.gov/ij/>; RRID: SCR_003070MaxQuant\[[@bib53]\]Version 1.3.0.5; RRID: SCR_014485Skyline\[[@bib54]\]Version 3.6.0.10162; RRID: SCR_014080ZEN softwareZeiss<https://www.zeiss.com/>ImarisBitplaneVersion 8; RRID: SCR_007370iLIR\[[@bib23]\]N/AGraphPad PrismGraphPad SoftwareVersion 6; RRID: SCR_002798**Other**Zeiss LSM 710 confocal microscopeZeiss; The Francis Crick Institute<https://www.zeiss.com/>MultiPep automated peptide synthesizerINTAVIS Bioanalytical Instruments AG, Germany \[[@bib55]\]; The Francis Crick InstituteN/AUltiMate 3000 RSLCnano SystemThermo Fisher Scientific; The Francis Crick InstituteCat\#ULTIM3000RSLCNANO50-cm EasySpray PepMap columnThermo Fisher Scientific; The Francis Crick InstituteN/AEasySpray nano sourceThermo Fisher Scientific; The Francis Crick InstituteN/AQ Exactive mass spectrometerThermo Fisher Scientific; The Francis Crick InstituteN/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Sharon A. Tooze (<sharon.tooze@crick.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell lines and culture {#sec4.3.1}

HEK293A, U2OS, RPE-1, MEF GFP-DFCP1, HEK293 GFP-WIPI2b, HEK293 GFP-DFCP1 and their derivatives were grown in a humidified incubator at 37°C in 10% CO~2~ in full medium: DMEM supplemented with 10% (20% for RPE-1 cells) fetal calf serum and 4 mM L-glutamine. To induce autophagy, cells were washed 3 times with Earle's balanced salt solution (EBSS) and incubated in EBSS for two hours. Where indicated, cells were treated with: 100 μg/mL Cycloheximide, 100 nM Bafilomycin A1 (Calbiochem), 10 μM MG132 (Calbiochem) or 50 μM Nocodazole (Sigma) for the specified time. GFP-DFCP1 MEF cells were a kind gift from Noboru Mizushima, (University of Tokoyo, Japan). The HEK293 GFP-WIPI2b stably expressing cells were as described \[[@bib3]\]. RPE-1 control and CRISPR/Cas9 PCM1 knockout cells were as described \[[@bib17]\]. HEK293 Flp-In T-Rex GFP-GABARAP cells were maintained in full medium + 200 μg/ml Hygromycin B + 5 μg/ml Blasticidin and induced for 24 hr with 1 μg/ml tetracycline in full medium to express GFP-GABARAP. HEK293 Flp-In T-Rex GFP-GABARAP cells were a kind gift from Anne Simonsen, (University of Oslo, Norway). The HEK293 GFP-DFCP1 stably expressing cells were a gift from N. Ktistakis (clone 201) \[[@bib56]\] and maintained in the presence of G418 at μg/ml.

### Organisms for recombinant protein expression {#sec4.3.2}

*Escherichia coli* cells were cultured in LB medium (see [Method Details](#sec4.4){ref-type="sec"}).

Method Details {#sec4.4}
--------------

### siRNA/DNA transfection and antibodies {#sec4.4.1}

Lipofectamine 2000 (Life Technologies) was used for transient transfection of cells according to the manufacturer's instructions. DNA plasmids were used at a concentration of 1 μg/mL of transfection mix. Where indicated 3xFLAG pLVX-IRES-PURO was used as a vector control. For RNAi, cells were transfected with the relevant siRNA oligo using Lipofectamine 2000 (Life Technologies). Cells were harvested 72 hr after transfection. Final concentration of siRNA oligos was 37.5 nM. siRNA oligos used (Dharmacon): D-001220-01 (RISC-Free, control), D-012368-02 (GABARAP) and D-005165-01 (PCM1).

EGFP-PCM1 (pEGFP C2) 3xAla D1954A, F1955A, V1958A point mutations were generated by using QuikChange Multi Site-Directed Mutagenesis Kit (Agilent Technologies). EGFP-PCM1 wild-type and 3xAla constructs resistant to PCM1 siRNA D-005165-01 (Dharmacon) were generated using Q5 Site-Directed Mutagenesis Kit (NEB, E0554S). 3xFLAG pLVX-IRES-PURO, 3xFLAG-Mib1 pLVX-IRES-PURO and 3xFLAG-Mib1 C985S pLVX-IRES-PURO were as described \[[@bib17]\]. FLAG-Mib1 pCDNA 3 truncations aa1-729, aa730-1007, aa1-429, aa430-1007, aa430-1007, aa430-729, aa820-1007 and C997S mutant were a gift from Jason Berndt (Howard Hughes Medical Institute, USA) and as described \[[@bib34]\]. EGFP-PCM1 (NP_001302436) (pEGFP C2) and S372A/E were gifts from Takashi Toda (Hiroshima University, Japan) \[[@bib33]\]. pDEST EGFP-mAtg8 homologs and pDEST-myc-GABARAP (human) were a gift from Terje Johansen (UiT, The Arctic University of Norway, Tromsø). pDEST-EGFP-GABARAP G116A mutant was generated by us previously \[[@bib13]\].

Mouse antibodies: anti-Vinculin (Sigma, V9264), anti-GABARAP (MBL, M135-3) for immunoprecipitation, anti-LC3 for IF (5F10) (Nanotools, 0231-100/LC3-5F10), anti-GM130 (for IF) (BD Biosciences, 610822), anti-PCM1 (for WB Atlas antibodies, AMAb90565; for IF Sigma, SAB1406228), anti-ubiquitin (FK2) (MBL, D058-3), anti-γ-tubulin ascites (Sigma, GTU-88, T6557), anti-p62 (BD Biosciences, 610832; Abnova, H00008878-M01), anti-FLAG M2 (Sigma), anti-GFP (CRUK, 3E1), anti-WIPI2 \[[@bib50]\]. Rabbit antibodies: anti-Pericentrin (Abcam, ab4448), anti-Mib1 (Sigma, M5948), anti-Ubiquitin Lys48 linked (APU2) (Millipore, 05-1307), anti-Ubiquitin Lys63 linked (APU3) (Millipore, 05-1308), anti-PCM1 (for IF, Cell Signaling, 5213), anti-ULK1 (for WB, Santa Cruz, sc-33182; for IF, Cell Signaling, 8054 D8H5), anti-GABARAP (Abgent, AP1821a), anti-NBR1 (D2E6) (Cell Signaling, 9891), anti-HA (Covance, PRB-101C), anti-WIPI2 \[[@bib50]\], anti-Actin (Abcam, ab8227), anti-LC3 for WB (Abcam, ab48394). Hamster antibodies: anti-Atg9 \[[@bib51]\]. Guinea pig antibodies: anti-p62 (for IF) (Progen, GP62-C). Goat antibodies: anti-SSX2IP (ThermoFisher, PA5-18258), anti-γ-tubulin (C-20) (Santa Cruz, sc-7396). Antibodies were used at manufacturer's suggested concentrations. Secondary antibodies for IF, from Life Technologies unless otherwise specified, were anti-rabbit IgG Alexa Fluor 488, 555 and 647, anti-mouse IgG Alexa Fluor 488, 647 and 350, anti-goat IgG Alexa Fluor 647, anti-guinea pig Alexa Fluor 555 and anti-hamster Cy3 (Jackson ImmunoResearch). HRP-conjugated secondary antibodies used for WB were from GE Healthcare.

### Western Blotting {#sec4.4.2}

Cells were lysed in ice-cold TNTE buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% w/v Triton X-100, 5 mM EDTA) containing EDTA-free Complete Protease Inhibitor cocktail (Roche) and PhosSTOP (Roche). Lysates were cleared by centrifugation and resolved on NuPAGE Bis-Tris 4%--12% gels (Life Technologies) (or 4%--20% Tris-Glycine gels for GABARAP lipidation assays) followed by transfer onto a PVDF membrane (Millipore). Following incubation with primary and secondary antibodies the blots were developed by enhanced chemiluminescence (GE Healthcare). Densitometry was performed with ImageJ software. For western blotting of weak signal antibodies, primary antibody was diluted with SignalBoost Immunoreaction Enhancer Kit (Merck Millipore, 407207) and blots were developed with Luminata Crescendo Western HRP substrate (Merck Millipore).

### Immunoprecipitation {#sec4.4.3}

Cells were lysed using TNTE buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 1x Complete protease inhibitor (Roche), 1x PhosSTOP (Roche)) supplemented with 10% (v/v) glycerol and 0.1% (w/v) BSA and the clarified lysates used for immunoprecipitation using the indicated antibodies for 2 hr at 4°C. Antibodies were coupled to protein G Sepharose (Sigma). Pelleted beads were washed 3 times with TNTE buffer and eluted with 2x Laemmli sample buffer at 100°C for 10 min before resolving by SDS-PAGE (4%--12% Bis-Tris NuPAGE gels, Life Technologies) and western blotting. GFP-tagged proteins were immunoprecipitated using GFP-TRAP beads and HA-tagged proteins with anti-HA affinity matrix 3F10 (Roche), using the same buffer and protocol. During western blotting of IP experiments, TrueBlot (Rockland) was used to reduce background from IgG when required.

### Immunoisolation of GFP-DFCP1 membranes {#sec4.4.4}

HEK293 cells stably expressing GFP-DFCP1 were treated with EBSS for 2 hr. Cells were then washed in ice cold PBS and harvested by centrifugation at 200 x g at 4°C. Pellets were resuspended using an ice cold buffer (20mM HEPES, pH 7.4; 250mM sucrose; 1mM EDTA) supplemented with EDTA-free Complete protease inhibitor cocktail (Roche). The resuspended pellet was then passed through a 27G needle for homogenization before clarification by centrifugation at 3000 x g at 4°C. Supernatants were used for incubation overnight at 4°C with mouse anti-GFP antibody protein A Dynabeads. The GFP-DFCP1-positive membranes on the beads were then washed 3 times (20mM HEPES, pH 7.4; 250mM sucrose; 1mM EDTA:75mM NaCl) and eluted with 2x laemmli sample buffer before resolving by SDS-PAGE and western blotting.

### GST pulldowns {#sec4.4.5}

GST or GST-GABARAP was expressed in *E. coli* BL21-CodonPlus(DE3)-RIL (Agilent) cells in LB medium. Human GST-GABARAP pGEX-5X-1 was a gift from Zvulun Elazar (Weizmann Institute of Science, Israel). Expression was induced by addition of 1 mM IPTG at OD~600~ = 0.6 and cells were incubated at 37°C for 4 hr. Harvested cells were lysed using sonication on ice in a lysis buffer (PBSA + 1% Triton X-100, supplemented with 1 x Complete protease inhibitor (Roche)) and the clarified supernatant was subsequently applied to Glutathione Sepharose 4B beads (GE Healthcare). After several washes with (PBSA + 1% Triton X-100 + 500 mM NaCl supplemented with 1 x Complete protease inhibitor (Roche)), fusion protein-bound beads were used directly in GST pulldown assays. For GST pulldowns, HEK293A lysate was incubated with immobilized GST or GST-GABARAP on glutathione beads for 2 hr at 4°C in TNTE buffer supplemented with 10% (v/v) glycerol and 0.1% (w/v) BSA. Beads were then washed 3 x with TNTE before SDS-PAGE and western blotting.

### Peptide Arrays and GST Overlay Assay {#sec4.4.6}

SPOT synthesis of peptide arrays on cellulose membranes were performed using a MultiPep automated peptide synthesizer (INTAVIS Bioanalytical Instruments AG, Germany) as previously described \[[@bib55]\]. After blocking the cellulose membranes in TBST with 5% nonfat dry milk, peptide interactions with GST or GST fusion proteins were tested by overlaying the membranes with 1 μg/ml of recombinant protein for 2 hr at room temperature. Filters were washed in TBST, and bound proteins were detected with HRP-conjugated anti-GST antibody (1:5000; clone RPN1236; GE Healthcare).

### Ubiquitination assays {#sec4.4.7}

Where indicated cells were treated with 10 μM MG132 for 5 hr prior to lysis. To inhibit deubiquitinases cells were lysed in TNTE buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 1x Complete protease inhibitor (Roche), 1x PhosSTOP (Roche)) supplemented with 20 mM N-Ethylmaleimide (NEM) prior to immunoprecipitation as described. Where indicated GFP-TRAP immunoprecipitates were washed 3 x in denaturing buffer (8 M Urea, 1% SDS in PBS) at room temperature before SDS-PAGE to remove binding partners.

Alternatively cells were lysed in boiling SDS buffer (2% SDS, 1 mM EDTA, 50 mM NaF, preheated at 110°C) and then diluted with 4 volumes of dilution buffer (2.5% Triton X-100, 12.5 mM Tris pH 7.5, 187.5 mM NaCl and 1x Complete protease inhibitor (Roche), 1x PhosSTOP (Roche)) to a final concentration of 0.4% SDS, 2% TX100. Diluted lysates were clarified by centrifugation and subjected to anti-HA immunoprecipitation overnight. Immunoprecipitates were washed 3x with wash buffer (1 volume SDS buffer, 4 volumes dilution buffer) before SDS-PAGE.

### Ubiquitination mass spectrometry {#sec4.4.8}

Cells were lysed in ice-cold buffer (Tris-HCl 20 mM pH6.8, 0.5% (w/v) Triton X-100, 150 mM NaCl, 5 mM EDTA, phosphatase inhibitor cocktail and mammalian protease inhibitor cocktail \[Roche\], and 20 mM N-Ethylmaleimide). The lysates were then clarified by centrifugation (5 min, full speed, 4°C) and the supernatants containing GFP-GABARAP ubiquitinated conjugates were subjected to immunoprecipitation at 4°C with GFP-TRAP beads for 2 hr. Immunoprecipitates were washed three times with stringent denaturing washing buffer (8 M Urea, 1% SDS in PBS) at room temperature to remove GABARAP binding partners and then once with 10 mM Tris pH 7.5 before preparation for SDS-PAGE. Proteins were resolved by SDS-PAGE, fixed, and stained with GelCode, and gel slices subjected to tryptic digestion and mass spectrometry analysis (below).

Three bands covering an entire SDS-PAGE lane were excised for each sample. The excised gel pieces were de-stained with 50% acetonitrile, 100 mM ammonium bicarbonate, reduced with 10 mM DTT and alkylated with 20 mM chloroacetamide (all reagents from Sigma-Aldrich). After alkylation, the proteins were digested with 350 ng trypsin overnight at 37°C. The resulting peptides were extracted in 0.1% TFA and speed vacuum dried. For MS analysis, peptides were re-suspended in 0.1% TFA and loaded onto 50-cm Easy Spray PepMap column (Thermo Fisher Scientific). Reverse phase chromatography was performed using the RSLC nano U3000 (Thermo Fisher Scientific) with a binary buffer system at a flow rate of 250 nL/min. The in-gel digested samples were run on a linear gradient of solvent B (2- 40%) in 34 min, total run time of 60 min including column conditioning. The nanoLC was coupled to a Q Exactive mass spectrometer using an EasySpray nano source (Thermo Fisher Scientific). The Q Exactive was operated in data-dependent acquisition mode acquiring HCD MS/MS scans (R = 17,500) after an MS1 scan (R = 70, 000) on the 10 most abundant ions using MS1 target of 1 × 10^6^ ions, and MS2 target of 5 × 10^4^ ions. The maximum ion injection time utilized for MS2 scans was 120 ms, the HCD normalized collision energy was set at 28, the dynamic exclusion was set at 10 s, and the peptide match and isotope exclusion functions were enabled.

For the PRM (Parallel Reaction Monitoring) experiments, the QExactive was operated in data independent mode. A full scan MS1 was measured at 70,000 resolution (AGC target 1 × 10^6^, 200 ms maximum injection time, m/z 300−1200) followed by seven PRM scans at 17,500 resolution as triggered by an inclusion list. (AGC target 2 × 10^5^, 50 ms maximum injection time). Ion activation/dissociation was performed using HCD at normalized collision energy of 28.

For identification of diGly containing peptides, raw data files were analyzed with MaxQuant software (version 1.3.0.5) as described previously \[[@bib53]\]. Parent ion and tandem mass spectra were searched against UniprotKB *Homo sapiens* database. A list of 247 common laboratory contaminants provided by MaxQuant was also added to the database. For the search the enzyme specificity was set to trypsin with maximum of three missed cleavages. The precursor mass tolerance was set to 20 ppm for the first search (used for mass re-calibration) and to 6 ppm for the main search. Carbamidomethylation of cysteines was specified as fixed modification, oxidized methionines, N-terminal protein acetylation and di-glycine-lysine were searched as variable modifications. The datasets were filtered on posterior error probability to achieve 1% false discovery rate on protein, peptide and site level.

The PRM data was analyzed using Skyline 3.6.0.10162 software \[[@bib54]\]. The spectral library was built in Skyline using the MaxQuant msms.txt file and the BiblioSpec algorithm. The background proteome was generated using UniprotKB *Homo sapiens* database. Precursor and product ion extracted chromatograms (XICs) were generated using the following settings in Skyline. Signal extraction was performed on +2, +3, +4 precursor ions and +1 and +2 b and y fragment ions. Retention time filtering was restricted during import to be within 5 min of MS/MS ID times and ion mass tolerance was set to 0.055 m/z. A peptide was considered identified if at least five overlapping transitions were detected. Quantitation was performed using MS1 XICs where three replicate measurements were performed. To confirm that the changes in abundance of the diGly containing peptides are not a result of changes in the overall abundance of the GABARAP protein, four unmodified peptides were also quantified (normalization peptides, [Figure S5](#mmc1){ref-type="supplementary-material"}K).

Two GABARAP ubiquitination sites, lysine 13 (K13) and lysine 23 (K23), were identified by mass spectrometry on three different peptides ([Figure 7](#fig7){ref-type="fig"}K). Peptides containing these sites were quantified using integration of precursor ion signals with Skyline software. All measurements were done in triplicates and the mean and standard error of the peak area is displayed. To confirm that the total amount of the GABARAP protein is constant, four normalization peptides (unmodified) were also quantified ([Figure S5](#mmc1){ref-type="supplementary-material"}K).

### Confocal microscopy {#sec4.4.9}

Cells were grown on coverslips, fixed with 3% paraformaldehyde in PBS for 20 min before permeabilization with either, 0.2% Triton X-100 or 50 ug/mL digitonin in PBS for 3 min (ULK1 or ATG9 staining, respectively), or room temperature methanol for 5 min (all other antibodies). Coverslips were then blocked in 5% BSA in PBS (Roche) in PBS for 20 min. Coverslips were incubated with primary antibody in 1% BSA in PBS 1 hr at room temperature or 4°C overnight (ULK1 only). Coverslips were washed and incubated with secondary antibody in the same buffer as primary for 1 hr, before final washing with PBS and water. Images were acquired using a Zeiss LSM 710 confocal microscope and ZEN imaging software.

### Confocal data quantification {#sec4.4.10}

Puncta formation and centrosomal intensity was quantified by Imaris image analysis software. For autophagosomal puncta formation, the Imaris 'Spots' function was used to segment puncta. Cells were counted manually. Spots per cell numbers were derived for whole fields of cells with 10 fields per condition, per experiment captured. Typically \> 100 cells per condition per experiment were analyzed. A detailed protocol for spot counting autophagosomes using Imaris has previously been published \[[@bib57]\]. Centrosomal intensity quantification of GABARAP and γ-tubulin was performed similarly using Imaris software. The 'Surfaces' function of Imaris was used to create a mask on the centrosomes (γ-tubulin signal) and the amount of GABARAP and γ-tubulin signal at this mask was quantified for individual centrosomes, as shown in [Figure 4](#fig4){ref-type="fig"}B. The arbitrary signal intensity values were normalized to the mean of the RISC Free values to create a normalized RISC Free mean of 1.

Pearson's correlation coefficient was calculated per cell using the colocalization algorithm in Imaris. Non-centrosomal intracellular regions were chosen for analysis. Intracellular regions did not encompass the whole cytoplasmic area but rather a portion of a cell's cytoplasm. Images were quantified from 2 experiments, in total: RISC Free 15 images, siPCM1 9 images and GABARAP-p62 16 images.

### Correlative Light and Electron Microscopy {#sec4.4.11}

Correlative light and electron microscopy (CLEM) was performed as previously described \[[@bib58]\]. HEK293A cells were fixed with PFA 2% + Glutaraldehyde 2% in PBS, followed by 0.2% Triton X-100 in PBS permeabilization and 2 × 5 min washes in 10% BSA in PBS. Cells were stained with the indicated antibodies as described above.

### Primers used in this study {#sec4.4.12}

PrimerDescriptionSequence (5′-3′)PCM1 SDM Primer 3xAlaMutation of hPCM1 (NP_001302436) LIR motif aa1953-EDFVKV-aa1958 to EAAVKACTG GTA ATA TAA GTC AAA AGT CTG ATG AAG AAG CTG CTG TAA AAG CTG AAG ATT TAC CAC TGA AAC TGA CAA TAT ATT CPCM1 SDM Primer siRNA resistant ForwardSilent mutations of hPCM1 (NP_001302436) to make resistant to Dharmacon siRNA D-005165-01cgt cgg aaa AGA ATA AGA AAA AGT TTG GTG TAGPCM1 SDM Primer siRNA resistant ReverseSilent mutations of hPCM1 (NP_001302436) to make resistant to Dharmacon siRNA D-005165-01acc tgt tcg cTT TCT TCT GTT GGG CAC C

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

The statistical details of all experiments are reported in the figure legends and figures, including statistical analysis performed, error bars, statistical significance and exact n numbers. Statistics were performed using GraphPad Prism 6 software, as detailed in the figure legends. For further details of confocal data analysis and mass spectrometry data analysis and software used see [Method Details](#sec4.4){ref-type="sec"}.

Data and Software Availability {#sec4.6}
------------------------------

The protein interactions from this publication have been submitted to the IMEx (<http://www.imexconsortium.org>) consortium through IntAct \[[@bib52]\] and assigned the identifier IM-25779.
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